Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Go back to Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
StemCells, Inc. (NASDAQ: TEM) Delayed: 48.94 -1.9 (3.74%)
Previous Close $50.84    52 Week High $0.45 
Open $49.75    52 Week Low $0.37 
Day High $51.27    P/E N/A 
Day Low $47.64    EPS $-0.31 
Volume 2,957,859